Blankinship & Foster’s MediciNova MNOV Stock Holding History

Blankinship & Foster’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,700	Closed	-$33.9K	–	56
2023 Q1	$33.9K	Hold	15,700	–	–	0.01%	53
2022 Q4	$32.2K	Hold	15,700	–	–	0.01%	54
2022 Q3	$34K	Hold	15,700	–	–	0.02%	52
2022 Q2	$40K	Hold	15,700	–	–	0.02%	54
2022 Q1	$42K	Hold	15,700	–	–	0.02%	53
2021 Q4	$42K	Hold	15,700	–	–	0.02%	53
2021 Q3	$60K	Hold	15,700	–	–	0.02%	52
2021 Q2	$67K	Hold	15,700	–	–	0.03%	51
2021 Q1	$79K	Hold	15,700	–	–	0.03%	56
2020 Q4	$83K	Hold	15,700	–	–	0.03%	52
2020 Q3	$82K	Hold	15,700	–	–	0.04%	49
2020 Q2	$85K	Hold	15,700	–	–	0.04%	43
2020 Q1	$58K	Hold	15,700	–	–	0.04%	42
2019 Q4	$106K	Hold	15,700	–	–	0.06%	48
2019 Q3	$125K	Hold	15,700	–	–	0.07%	44
2019 Q2	$151K	Hold	15,700	–	–	0.09%	47
2019 Q1	$130K	Hold	15,700	–	–	0.08%	49
2018 Q4	$128K	Hold	15,700	–	–	0.09%	43
2018 Q3	$196K	Hold	15,700	–	–	0.12%	42
2018 Q2	$125K	Hold	15,700	–	–	0.08%	37
2018 Q1	$160K	Hold	15,700	–	–	0.11%	37
2017 Q4	$102K	Hold	15,700	–	–	0.06%	38
2017 Q3	$100K	Hold	15,700	–	–	0.07%	32
2017 Q2	$83K	Hold	15,700	–	–	0.07%	29
2017 Q1	$94K	Buy	+15,700	New	+$94.6K	0.08%	26

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Blankinship & Foster's MNOV Position: Q2 2023 in Review

Blankinship & Foster sold out of MediciNova (MNOV) in Q2 2023, closing a stake of 15,700 shares — an estimated $33.9K sold.

Blankinship & Foster first reported a position in MNOV in Q1 2017 and held it in 25 quarters. The position peaked at $196K in Q3 2018. 34 funds tracked by Wall St. Rank hold MNOV as of Q2 2023.

Blankinship & Foster reported no remaining MediciNova position as of Q2 2023 after selling out during the quarter.
Blankinship & Foster sold 15,700 MediciNova shares in Q2 2023, an estimated $33.9K.
Blankinship & Foster first reported a position in MediciNova in Q1 2017 and held it in 25 quarters.
Blankinship & Foster's MediciNova position peaked at $196K in Q3 2018.
34 funds tracked by Wall St. Rank held MediciNova as of Q2 2023.

Based on Blankinship & Foster's 13F filing for Q2 2023, filed 24 Jul 2023.